Eclipsys Marks Continued Double-Digit Growth in Pharmacy Activations

The Hospital of the University of Pennsylvania (HUP), one of the top 10 hospitals in the nation, is one of the latest healthcare organizations to activate the Sunrise Pharmacy(TM) integrated pharmacy information system. The successful go live, which replaces a competitive legacy pharmacy solution, builds upon HUP's 100 percent adoption of Eclipsys' computerized physician order entry (CPOE) solution for more informed clinical decision making and support. Plans call for a continued rollout of Eclipsys' medication management solutions at HUP and at other University of Pennsylvania Health System hospitals.

"As a Magnet hospital, we have an intense focus on patient care and safety, and in reviewing replacement pharmacy solutions, we opted for Eclipsys because it offered the most viable solution to meet those goals," said Michael Restuccia, vice president and chief information officer, University of Pennsylvania Health System. "We are strong believers in integration, and the integration between the Eclipsys pharmacy solution and CPOE system provides us with the foundation for the safety benefits that come with closed loop medication administration. It effectively links our caregivers with our pharmacists for enhanced communications and collaboration because they are viewing the same screen and using a single database for patients' drug therapy."

HUP's activation of the pharmacy solution became a next step for its physicians, who have accepted the new system as an enhanced ordering capability. In addition, HUP pharmacists are now afforded more mobility and efficiency in viewing orders and have the ability to spend more time with physicians and patients.

Restuccia added, "In a complex environment, such as HUP, we treat extremely high acuity patients, and that type of treatment environment requires a very precise and easy-to-use system to gain physician adoption. Eclipsys' CPOE system is well-suited in complex environments, as well as standard acute care environments. It's because of that level of CPOE adoption that the pharmacy activation became so seamless within the physician community."

Pharmacy Activations Support Meeting Medication Management Component of ARRA

"In light of the longer-term impact of the American Recovery and Reinvestment Act (ARRA), which ultimately translates 'meaningful use' into a pay for performance reimbursement scenario, healthcare organizations need to reconsider their levels of clinical system integration," said Jay Deady, Eclipsys' executive vice president of Client Solutions. "The superior integration between our pharmacy and CPOE solution not only offers tremendous patient safety and workflow efficiencies, we believe it will be a key factor for our clients in meeting the medication management component of ARRA in the near term, and more important, the outcome requirements as the bar will continue to rise."

In addition to HUP, clients to recently adopt the Eclipsys pharmacy solution include:

-- Athens Regional Medical Center (Athens, GA)

-- Baylor Medical Center at Grapevine (Grapevine, TX)

-- Carson Tahoe Regional Medical Center (Carson City, NV)

-- El Camino Hospital (Mountain View, CA; Los Gatos, CA)

-- HealthFirst (Palm Bay, FL; Cape Canaveral, FL)

-- Hospital for Special Surgery (New York, NY)

-- Lenox Hill Hospital (New York, NY)

-- Liberty Hospital (Liberty, MO)

-- Presbyterian Intercommunity Hospital (Whittier, CA)

-- Robert Wood Johnson (Hamilton, NJ)

-- St. Mary's of Michigan (Saginaw, MI)

-- SingHealth (Singapore)

-- SUNY Downstate Medical Center (Brooklyn, NY)

-- The Washington Hospital (Washington, PA)

-- University of Kentucky Medical Center (Lexington, KY)

-- University of Pennsylvania -- Rittenhouse (Philadelphia, PA)

A key factor to the market appeal of the Eclipsys pharmacy solution lies in its integration with the company's CPOE solution, Sunrise Acute Care(TM). Working in concert via a single database, the two systems enable integrated handoffs between clinicians and pharmacists resulting in fewer errors and accelerated time to treatment. In addition, according to the 2008 "Top 20 Best in KLAS Award: Software and Professional Services" report, issued by KLAS Enterprises, Inc., 92 percent of KLAS respondents indicated they would buy the Eclipsys pharmacy solution again.

Sunrise Pharmacy, a key component of Eclipsys' Sunrise Medication Management(TM) solution, enables pharmacists to quickly and easily enter, review and verify physician orders. The single application screen view helps the pharmacist to effectively manage multiple tasks and save time. Shared real-time information enhances the pharmacist's ability to deliver the patient's medications with greater accuracy and in less time, even when a physician goes back and modifies or cancels an order placed earlier. In addition, advanced clinical decision support for checking medication contraindications helps to reduce adverse drug events.

About KLAS

KLAS is a research firm specializing in monitoring and reporting the performance of healthcare vendors. KLAS' mission is to improve delivery, by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from over 4500 hospitals and over 2500 clinics, KLAS delivers timely reports, trends, and statistics, which provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, and medical equipment vendors. For more information, go to www.KLASresearch.com , or email marketing@KLASresearch.com , or call 1-800-920-4109 to speak with a KLAS representative.

About the 2008 Top 20 Best in KLAS Awards: Software and Professional Services report

The report reflects the summary of healthcare information technology (HIT) software and professional services performance data as reported by physician offices, clinics, IDNs, inpatient facilities, and applicable healthcare agencies. The HIT software ratings reflect data collected over the past 13 months (October 15, 2007 -- November 15, 2008); the professional services ratings reflect data collected over the past 18 months (May 15, 2007 -- November 15, 2008). Each product or segment is listed by market segment.

About Eclipsys

Eclipsys is a leading provider of advanced integrated clinical, revenue cycle and performance management software, clinical content and professional services that help healthcare organizations improve clinical, financial, and operational outcomes. For more information, see www.eclipsys.com or email info@eclipsys.com.

Statements in this news release concerning the timing of implementations and features and benefits provided by Eclipsys software and implementation services are forward-looking statements and actual results may differ from those projected due to a variety of risks and uncertainties. Implementation and customization of Eclipsys software is complex and time-consuming. Results depend upon a variety of factors and can vary by client. Each client's circumstances are unique and may include unforeseen issues that make it more difficult than anticipated to implement or derive benefit from Eclipsys software or services. The success and timeliness of the company's services will depend at least in part upon client involvement, which can be difficult to control. Eclipsys is required to meet specified performance standards, and the contract can be terminated or its scope reduced under certain circumstances. More information about company risks is available in recent Form 10-Q and 10-K filings made by Eclipsys from time to time with the Securities and Exchange Commission. Special attention is directed to the portions of those documents entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations." Eclipsys Corporation and The Outcomes Company are registered trademarks of Eclipsys Corporation. Sunrise Pharmacy, Sunrise Acute Care and Sunrise Medication Management are trademarks of Eclipsys Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.

SOURCE: Eclipsys Corporation

Eclipsys Corporation 
Robin Wrinn, 404-847-5219 
Director, Public Relations (media) 
robin.wrinn@eclipsys.com 
or 
Jason Cigarran, 404-847-5965 
Vice President, Investor Relations 
jason.cigarran@eclipsys.com